UK-based Purespring Therapeutics, a developer of gene therapies to halt or prevent kidney disease, has appointed Haseeb Ahmad as CEO and board member. He succeeds Julian Hanak, who has served…
UK: Purespring Therapeutics appoints Hasseeb Ahmad as CEO
…
…






